Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Prestin autoantibodies screening in idiopathic sudden sensorineural hearing loss.

Tovi H, Ovadia H, Eliashar R, de Jong MA, Gross M.

Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Apr;136(2):99-101. doi: 10.1016/j.anorl.2017.11.013. Epub 2018 Dec 31.

PMID:
30606654
2.

Androgen receptor: a potential therapeutic target for glioblastoma.

Zalcman N, Canello T, Ovadia H, Charbit H, Zelikovitch B, Mordechai A, Fellig Y, Rabani S, Shahar T, Lossos A, Lavon I.

Oncotarget. 2018 Apr 13;9(28):19980-19993. doi: 10.18632/oncotarget.25007. eCollection 2018 Apr 13.

3.

T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).

Vaknin-Dembinsky A, Brill L, Kassis I, Petrou P, Ovadia H, Ben-Hur T, Abramsky O, Karussis D.

Mult Scler Relat Disord. 2016 Mar;6:28-36. doi: 10.1016/j.msard.2015.12.004. Epub 2015 Dec 11.

PMID:
27063619
4.

Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.

Hasarmeh M, Itzik A, Weidenfeld J, Ovadia H.

Neuroimmunomodulation. 2016;23(1):1-7. doi: 10.1159/000441948. Epub 2015 Dec 16.

PMID:
26670748
5.

Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.

Binyamin O, Larush L, Frid K, Keller G, Friedman-Levi Y, Ovadia H, Abramsky O, Magdassi S, Gabizon R.

Int J Nanomedicine. 2015 Nov 20;10:7165-74. doi: 10.2147/IJN.S92704. eCollection 2015. Erratum in: Int J Nanomedicine. 2018 Aug 29;13:4845.

6.

Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid.

Erdinest N, Shohat N, Moallem E, Yahalom C, Mechoulam H, Anteby I, Ovadia H, Solomon A.

J Inflamm (Lond). 2015 Oct 25;12:59. doi: 10.1186/s12950-015-0104-1. eCollection 2015.

7.

Electrical stimulation of the amygdala modifies the negative feedback effect of glucocorticoids on the adrenocortical responses to stress.

Weidenfeld J, Itzik A, Ovadia H.

Neuroimmunomodulation. 2015;22(6):394-9. doi: 10.1159/000437332. Epub 2015 Sep 10.

8.

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.

Turjeman K, Bavli Y, Kizelsztein P, Schilt Y, Allon N, Katzir TB, Sasson E, Raviv U, Ovadia H, Barenholz Y.

PLoS One. 2015 Jul 6;10(7):e0130442. doi: 10.1371/journal.pone.0130442. eCollection 2015.

9.

Antineoplastic effect of decoy oligonucleotide derived from MGMT enhancer.

Canello T, Ovadia H, Refael M, Zrihan D, Siegal T, Lavon I.

PLoS One. 2014 Dec 2;9(12):e113854. doi: 10.1371/journal.pone.0113854. eCollection 2014.

10.

Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?

Brill L, Goldberg L, Karni A, Petrou P, Abramsky O, Ovadia H, Ben-Hur T, Karussis D, Vaknin-Dembinsky A.

Mult Scler. 2015 Apr;21(5):572-9. doi: 10.1177/1352458514551779. Epub 2014 Nov 12.

PMID:
25392324
11.

False negative β-2 transferrin in the diagnosis of cerebrospinal fluid leak in the presence of Streptococcus pneumoniae.

Korem M, Ovadia H, Paldor I, Moses AE, Block C, Eliashar R, Hirshoren N.

Laryngoscope. 2015 Mar;125(3):556-60. doi: 10.1002/lary.24940. Epub 2014 Sep 29.

PMID:
25265373
12.

Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD.

Mizrahi M, Friedman-Levi Y, Larush L, Frid K, Binyamin O, Dori D, Fainstein N, Ovadia H, Ben-Hur T, Magdassi S, Gabizon R.

Nanomedicine. 2014 Aug;10(6):1353-63. doi: 10.1016/j.nano.2014.03.015. Epub 2014 Apr 2.

PMID:
24704590
13.

Genetic prion disease: no role for the immune system in disease pathogenesis?

Friedman-Levi Y, Binyamin O, Frid K, Ovadia H, Gabizon R.

Hum Mol Genet. 2014 Aug 1;23(15):4134-41. doi: 10.1093/hmg/ddu134. Epub 2014 Mar 25. Erratum in: Hum Mol Genet. 2014 Nov 15;23(22):6138.

PMID:
24667414
14.

Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study.

Erdinest N, Ovadia H, Kormas R, Solomon A.

J Inflamm (Lond). 2014 Mar 2;11(1):6. doi: 10.1186/1476-9255-11-6.

15.

Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblasts.

Erdinest N, Aviel G, Moallem E, Anteby I, Yahalom C, Mechoulam H, Ovadia H, Solomon A.

J Inflamm (Lond). 2014 Feb 4;11(1):3. doi: 10.1186/1476-9255-11-3.

16.

Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.

Avraham HK, Jiang S, Fu Y, Nakshatri H, Ovadia H, Avraham S.

J Pathol. 2014 Feb;232(3):369-81. doi: 10.1002/path.4304.

PMID:
24421076
17.

Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria.

Waknine-Grinberg JH, Even-Chen S, Avichzer J, Turjeman K, Bentura-Marciano A, Haynes RK, Weiss L, Allon N, Ovadia H, Golenser J, Barenholz Y.

PLoS One. 2013 Aug 26;8(8):e72722. doi: 10.1371/journal.pone.0072722. eCollection 2013.

18.

Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.

Duchi S, Ovadia H, Touitou E.

J Neuroimmunol. 2013 May 15;258(1-2):32-40. doi: 10.1016/j.jneuroim.2013.02.013. Epub 2013 Mar 18.

PMID:
23517929
19.

[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].

Vaknin-Dembinsky A, Levin N, Raz N, Abramsky O, Karussis D, Brill L, Petrou P, Ovadia H.

Harefuah. 2013 Feb;152(2):101-5, 122. Hebrew.

PMID:
23513502
20.

Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.

Nov O, Shapiro H, Ovadia H, Tarnovscki T, Dvir I, Shemesh E, Kovsan J, Shelef I, Carmi Y, Voronov E, Apte RN, Lewis E, Haim Y, Konrad D, Bashan N, Rudich A.

PLoS One. 2013;8(1):e53626. doi: 10.1371/journal.pone.0053626. Epub 2013 Jan 16.

21.

Delayed effects of brain irradiation--part 1: adrenocortical axis dysfunction and hippocampal damage in an adult rat model.

Weidenfeld J, Siegal T, Ovadia H.

Neuroimmunomodulation. 2013;20(1):57-64. doi: 10.1159/000342522. Epub 2012 Nov 23.

PMID:
23183099
22.

Delayed central nervous system irradiation effects in rats--part 2: aggravation of experimental autoimmune encephalomyelitis.

Ovadia H, Siegal T, Weidenfeld J.

Neuroimmunomodulation. 2013;20(1):51-6. doi: 10.1159/000342528. Epub 2012 Nov 23.

PMID:
23183048
23.

T-cell reactivity against AQP4 in neuromyelitis optica.

Vaknin-Dembinsky A, Brill L, Kassis I, Petrou P, Ovadia H, Ben-Hur T, Abramsky O, Karussis D.

Neurology. 2012 Aug 28;79(9):945-6. doi: 10.1212/WNL.0b013e318266fc2b. Epub 2012 Aug 15. No abstract available.

PMID:
22895587
24.

Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells.

Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A.

Invest Ophthalmol Vis Sci. 2012 Jul 3;53(8):4396-406. doi: 10.1167/iovs.12-9724.

PMID:
22669722
25.

Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Friedman-Levi Y, Hoftberger R, Budka H, Mayer-Sonnenfeld T, Abramsky O, Ovadia H, Gabizon R.

J Neuroinflammation. 2012 Mar 21;9:58. doi: 10.1186/1742-2094-9-58.

26.

The function of the adrenocortical axis in permanent middle cerebral artery occlusion: effect of glucocorticoids on the neurological outcome.

Weidenfeld J, Leker RR, Gai N, Teichner A, Bener D, Ovadia H.

Brain Res. 2011 Aug 17;1407:90-6. doi: 10.1016/j.brainres.2011.06.035. Epub 2011 Jun 23.

PMID:
21741032
27.

Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity.

Ovadia H, Haim Y, Nov O, Almog O, Kovsan J, Bashan N, Benhar M, Rudich A.

J Biol Chem. 2011 Sep 2;286(35):30433-43. doi: 10.1074/jbc.M111.235945. Epub 2011 Jul 1.

28.

Neutralization of endogenous digitalis-like compounds alters catecholamines metabolism in the brain and elicits anti-depressive behavior.

Goldstein I, Lax E, Gispan-Herman I, Ovadia H, Rosen H, Yadid G, Lichtstein D.

Eur Neuropsychopharmacol. 2012 Jan;22(1):72-9. doi: 10.1016/j.euroneuro.2011.05.007. Epub 2011 Jun 22.

PMID:
21700431
29.

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis.

Lourbopoulos A, Grigoriadis N, Lagoudaki R, Touloumi O, Polyzoidou E, Mavromatis I, Tascos N, Breuer A, Ovadia H, Karussis D, Shohami E, Mechoulam R, Simeonidou C.

Brain Res. 2011 May 16;1390:126-41. doi: 10.1016/j.brainres.2011.03.020. Epub 2011 Mar 13.

PMID:
21406188
30.

The effect of herpes simplex virus-1 on nitric oxide synthase in the rat brain: the role of glucocorticoids.

Hasson J, Weidenfeld J, Mizrachi-Kol R, Ben-Hur T, Ovadia H.

Neuroimmunomodulation. 2011;18(2):111-6. doi: 10.1159/000320870. Epub 2010 Nov 10.

PMID:
21071988
31.

The effect of restraint stress on glucocorticoid receptors in mouse spleen lymphocytes: involvement of the sympathetic nervous system.

Warner A, Ovadia H, Tarcic N, Weidenfeld J.

Neuroimmunomodulation. 2010;17(5):298-304. doi: 10.1159/000292019. Epub 2010 Apr 17.

PMID:
20407281
32.

Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis.

Kizelsztein P, Ovadia H, Garbuzenko O, Sigal A, Barenholz Y.

J Neuroimmunol. 2009 Aug 18;213(1-2):20-5. doi: 10.1016/j.jneuroim.2009.05.019. Epub 2009 Jun 28.

PMID:
19564052
33.

Bacteria coated by polyphenols acquire potent oxidant-scavenging capacities.

Koren E, Kohen R, Ovadia H, Ginsburg I.

Exp Biol Med (Maywood). 2009 Aug;234(8):940-51. doi: 10.3181/0901-RM-22. Epub 2009 Jun 2.

PMID:
19491375
34.

Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species.

Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A.

Physiol Rev. 2009 Jan;89(1):27-71. doi: 10.1152/physrev.00014.2008. Review.

35.

Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.

Einav S, Itshayek E, Kark JD, Ovadia H, Weiniger CF, Shoshan Y.

BMC Clin Pathol. 2008 Sep 19;8:9. doi: 10.1186/1472-6890-8-9.

36.

Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.

Haviv Y, Avrahami D, Ovadia H, Ben-Hur T, Gabizon R, Sharon R.

Arch Neurol. 2008 Jun;65(6):762-75. doi: 10.1001/archneur.65.6.762.

PMID:
18541796
37.

Copaxone interferes with the PrP Sc-GAG interaction.

Engelstein R, Ovadia H, Gabizon R.

Eur J Neurol. 2007 Aug;14(8):877-84.

PMID:
17662008
38.

Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.

Friedman-Levi Y, Ovadia H, Hoftberger R, Einstein O, Abramsky O, Budka H, Gabizon R.

J Virol. 2007 Sep;81(18):9942-9. Epub 2007 Jul 11.

39.

The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release.

Wasserman V, Kizelsztein P, Garbuzenko O, Kohen R, Ovadia H, Tabakman R, Barenholz Y.

Langmuir. 2007 Feb 13;23(4):1937-47. Epub 2007 Jan 9.

PMID:
17279678
40.

Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.

Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, Ovadia H, Abramsky O.

Arch Neurol. 2006 Oct;63(10):1459-67.

PMID:
17030663
41.
42.

Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders.

Goldstein I, Levy T, Galili D, Ovadia H, Yirmiya R, Rosen H, Lichtstein D.

Biol Psychiatry. 2006 Sep 1;60(5):491-9. Epub 2006 May 19.

PMID:
16712803
43.

[Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].

Ovadia H, Karussis D, Abramsky O.

Harefuah. 2006 Apr;145(4):298-303, 317. Review. Hebrew.

PMID:
16642634
44.

Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes.

Khamaisi M, Keynan S, Bursztyn M, Dahan R, Reinhartz E, Ovadia H, Raz I.

Nephron Physiol. 2006;102(3-4):p72-80. Epub 2005 Nov 25.

PMID:
16319502
45.

Inhibition of P53-related apoptosis had no effect on PrP(Sc) accumulation and prion disease incubation time.

Engelstein R, Grigoriadis N, Greig NH, Ovadia H, Gabizon R.

Neurobiol Dis. 2005 Mar;18(2):282-5.

PMID:
15686956
46.

New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists.

Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, Rogers JT, Ovadia H, Lahiri DK.

Ann N Y Acad Sci. 2004 Dec;1035:290-315. Review.

PMID:
15681814
47.

Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures.

Yuhas Y, Weizman A, Chrousos GP, Ovadia H, Ashkenazi S.

J Neuroimmunol. 2004 Aug;153(1-2):36-9.

PMID:
15265661
48.

The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha.

Leker RR, Aharonowiz M, Greig NH, Ovadia H.

Exp Neurol. 2004 Jun;187(2):478-86.

PMID:
15144874
49.

The glucocorticoid receptor mediates the thymic epithelial cell-induced apoptosis of CD4+8+ thymic lymphoma cells.

Zilberman Y, Zafrir E, Ovadia H, Yefenof E, Guy R, Sionov RV.

Cell Immunol. 2004 Jan;227(1):12-23.

PMID:
15051511
50.

Rasmussen encephalitis with active inflammation and delayed seizures onset.

Korn-Lubetzki I, Bien CG, Bauer J, Gomori M, Wiendl H, Trajo L, Ovadia H, Wilken B, Hans VH, Elger CE, Hurvitz H, Steiner I.

Neurology. 2004 Mar 23;62(6):984-6.

PMID:
15037707

Supplemental Content

Loading ...
Support Center